On May 18, 2025, Joe Biden’s office confirmed he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone, as reported by the Associated Press via AJMC.
That single announcement put one question at the center of every conversation: What is Joe Biden’s life expectancy now?
His cancer is aggressive. His age places him in a statistical bracket that carries its own risks, cancer aside. His diagnosis is also described as hormone-sensitive, which means treatment options exist and can work.
This blog looks at what Social Security Administration actuarial data and the National Cancer Institute survival statistics tell us about Biden’s prostate cancer prognosis today and what it means for life expectancy for older adults with prostate cancer at this stage.
Joe Biden’s Current Health Status and Diagnosis
Most people heard “aggressive cancer” and stopped there. The actual diagnosis is more specific than that, and the specifics are what matter for understanding Biden’s prognosis.
Confirmed Facts About Biden’s Prostate Cancer
Three facts in Biden’s diagnosis matter above all others, and each one tells a different part of the story. His cancer is metastatic, his Gleason score is 9, and it is currently hormone-sensitive. Here is what each of those facts means in practice.
- Metastatic: The cancer has left the prostate and reached the bones. According to Boston University’s Shipley Prostate Cancer Research Center, bone-metastatic prostate cancer is “generally considered to be advanced and incurable.”
- Gleason score of 9: This places Biden in Grade Group 5, the top of the aggressiveness scale. Gerald Denis, a research professor at BU’s Shipley Center, said the pathologists’ reading of a Gleason 9 is that it “appears to be highly aggressive. This is not encouraging news.”
- Hormone-sensitive: The cancer still depends on testosterone to grow. That means androgen deprivation therapy (drugs that cut off the hormone supply) can slow tumor growth. Denis confirmed: “he can still be treated, and the progress of the cancer slowed, even if it is regarded as incurable.”
Age and Overall Health Context
Biden turns 83 in November 2025. That age matters when doctors assess his prognosis, though not in the way most people assume.
Doctors Todd M. Morgan and Tudor Borza at the University of Michigan Health Weiser Center for Prostate Cancer point out that the diagnosis “may not be grim, given recent advances in diagnosing and treating prostate cancer.” Their emphasis: survival outlook depends on the individual patient’s overall condition, not age alone.
Gerald Denis at Boston University adds a relevant fact. As he told BU Today, Biden has already outlived the average American male.
The average U.S. male lives to 75.8 years (2023 data), while the total population (males + females) lives to 78.4 years. Biden passed the male average more than six years ago.
What works in his favor beyond the hormone-sensitivity of his cancer:
- No reported major cardiovascular failure at the time of diagnosis. Heart disease is the leading cause of death among men his age, per the CDC NCHS 2024 Mortality Data Brief. Not having a history of cardiac disease is a real clinical asset at 82.
- Active public life up until recently. Denis notes that previous studies have linked vigorous physical activity, such as fast walking, to a lower risk of cancer spreading or worsening.
- Access to specialized oncology care. Former presidents receive care from highly focused medical teams. Research consistently shows that access to that level of treatment improves outcomes in older adults with metastatic prostate cancer.
That said, age above 80 brings compounding risks regardless of cancer. Infection, falls, and cardiac events all become more probable after that threshold. A Gleason 9 with bone spread pulls Biden’s prognosis below the baseline actuarial figure for his age group.
Hormone therapy in older men can also reduce bone density and raise cardiovascular risk over time, trade-offs his physicians must weigh with each treatment decision.
The most accurate answer to where his prognosis stands today: it depends more on how his cancer responds to treatment in the first 12 to 18 months than on any number drawn from an actuarial table.
Life Expectancy Statistics for Men of Biden’s Age
Biden has already outlived the average American man. That changes the math. The question is not how long men typically live. It is how long a man who has already reached 82 can expect to live from here.
Average U.S. Male Life Expectancy at 82-83
Most people treat life expectancy as a birth statistic. That figure is not the useful one for Biden. What matters here is remaining life expectancy, which is how many years a man who has already reached a given age can statistically expect to live.
The CDC National Center for Health Statistics United States Life Tables, 2023, shows that a U.S. male aged 82 has a remaining life expectancy of 7.5 years, putting his projected age at death at roughly 89.5. At 83, that drops to 7.0 additional years.
The birth figure tells a very different story. The CDC NCHS 2024 Mortality Data Brief puts male life expectancy at birth at 75.8 years in 2023, increasing to 76.5 years in 2024. Biden has already outlived the 2023 figure by more than six years.
The SSA Period Life Table (2022, used in the 2025 Trustees Report) puts remaining life expectancy for an 82-year-old man at 7.11 years. For each year beyond the average birth expectancy, the remaining figure is recalculated upward.
Here is how Biden’s age bracket compares against broader U.S. male population data:
| Age | Remaining Life Expectancy (U.S. Males) | Projected Age at Death |
|---|---|---|
| 80 | 8.5 years | ~88.5 |
| 82 | 7.1 years | ~89.1 |
| 83 | 6.6 years | ~89.6 |
| 85 | 5.8 years | ~90.8 |
Without his cancer diagnosis, Biden’s age alone would statistically project his life into the late 80s. His diagnosis changes that calculation in ways the table cannot capture on its own.
Adjusted Estimates Considering Health and Lifestyle
Actuarial tables average across the entire U.S. male population. Biden is not that average, and that fact points in two directions.
What favors a longer outlook:
- Heart disease is the top killer of American men his age, per CDC NCHS data. Biden had no major cardiac event on record at the time of diagnosis. At 82, that matters.
- Denis at BU’s Shipley Center points to research linking vigorous physical activity to lower rates of disease progression and mortality. Biden’s active public schedule up to his diagnosis works in his favor here.
- Doctors Morgan and Borza at the University of Michigan Health Weiser Center note that recent treatment advances mean the outlook for men with Biden’s diagnosis “may not be grim.”
What complicates it:
- Bone spread with a Gleason 9 pulls his prognosis below the actuarial average for 82-year-old men.
- Infections, falls, and cardiac events become more probable past 80, independent of the cancer.
- Hormone therapy carries its own risks in older men, including bone density loss and cardiovascular strain.
Expert Projections for Biden’s Life Expectancy
Ask a statistician about Biden’s prognosis, and you get one answer. Ask the oncologists who treat this cancer for a living, and you get a more specific one. The gap between those two answers is worth understanding.
Insights from Oncologists and Geriatric Specialists
When oncologists assess a case like Biden’s, they weigh four factors above everything else. Boston University’s Shipley Prostate Cancer Research Center identifies them as:
- Cancer stage and spread: Biden’s cancer has reached the bones, placing it in the most advanced disease category.
- Gleason score: A score of 9 means high-grade cells with strong potential for rapid spread if left untreated.
- Overall health at diagnosis: Physical condition, absence of major organ failure, and functional mobility all shape how well a patient tolerates treatment.
- Treatment responsiveness: Hormone-sensitive cancer gives physicians a real window to slow progression before the disease becomes treatment-resistant.
Dr. Tanya Dorff, an oncologist at City of Hope Comprehensive Cancer Center, told CBS News that patients diagnosed with aggressive, advanced-stage prostate cancer “can live many years and have a good quality of life.”
For Biden at Stage M1, the clinical goal is not a cure. It is control: slowing the spread and keeping him functional.
Dr. Tudor Borza at the University of Michigan Health adds a variable that has not been made public: the actual extent of bone involvement.
One metastatic focus carries a different prognosis than widespread skeletal involvement. Without that information, any projection carries real uncertainty.
CBS News medical contributor Dr. Celine Gounder confirmed that Biden’s bone metastases place him in Stage M1 disease, in the high/very high-risk management group, per CBS News reporting. Managing the disease, not eliminating it, is the immediate clinical priority.
Range of Estimated Life Expectancy
Oncologists not involved in Biden’s care have gone on record with projections. Their estimates form a clear spread. The conservative end is: 4-5 years.
Dr. Matthew Smith of Massachusetts General Brigham Cancer Center told the Associated Press that men with metastatic prostate cancer can generally expect to live four to five years. Dr. Sandy Srinivas, a medical oncologist at Stanford University, told ABC News that living another four to five years with Biden’s diagnosis “wouldn’t be out of the ordinary.”
NCI data cited by AJMC puts the five-year survival rate for metastatic prostate cancer at 37%. Roughly one in three men with this diagnosis are alive at the five-year mark. The optimistic end is: 5-10 years.
Dr. Herbert Lepor, a urologic oncologist at NYU Langone, told Reuters that patients with metastatic prostate cancer can survive five to ten years and beyond, particularly those whose cancer stays hormone-sensitive and responds well to treatment.
A 2024 study in the Journal of the American Geriatrics Society found that in real-world data, men aged 80 and older with metastatic hormone-sensitive prostate cancer had a median overall survival of 60 months (five years).
Men aged 75 to 79 had 64 months. Men aged 70 to 74 had 76 months. The age gap exists, but is not as wide as most people would expect.
| Scenario | Estimated Range | Key Condition |
|---|---|---|
| Conservative | 4-5 years | Average population outcomes |
| Moderate | 5-7 years | Good initial hormone response |
| Optimistic | 7-10 years | Strong response, no rapid resistance |
Denis at Boston University said it plainly: population-level survival numbers often look very different from what any one patient actually experiences. As he told BU Today: “There are many unknown factors that determine the clinical course in each case.”
How Joe Biden’s Life Expectancy Affects Public and Personal Life
At 82, with a stage M1 cancer diagnosis, Biden’s life looks different from what it did in January. The clinical goal has shifted. So has the public conversation around him. Both of those things matter, and they are connected in ways worth looking at closely.
Maintaining Public Engagement and Quality of Life
Before May 18, 2025, the dominant conversation about Biden was his age. After the announcement, it shifted to something more specific: how long he can remain active and what life realistically looks like from this point.
Oncologists are more measured on that question than most headlines have been.
Dr. Dorff at City of Hope told CBS News that the clinical goal for Biden at Stage M1 is management over cure. In practice, that means slowing the spread, preserving physical function, and extending time. Not weeks but years, if treatment works.
Biden addressed his diagnosis publicly on social media, writing: “Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places.”
For a man who has spent more than five decades in public life, the personal and political dimensions of his health are hard to fully separate at 82.
What happened clinically after the announcement was telling. Urology Times and HCPLive reported that urologists across the U.S. saw a noticeable increase in patient questions about PSA testing.
Older men asked more. Anxiety went up. Biden’s public disclosure pushed real medical conversations between men and their doctors that would not otherwise have happened that week.
His own treatment plan targets one realistic goal: slow the cancer, stay functional, and preserve quality of life for as long as possible. Whether that plays out over four years or ten depends on how his tumor responds to therapy in the months ahead.
Broader Health Message for Older Adults Through Biden’s Own Story
Biden’s case has a specific lesson attached, and it starts with a timeline. According to his own spokesperson, his last prostate cancer screening was in 2014, when he was 71 or 72 and still vice president.
That is an 11-year gap before bone-metastatic cancer was found. CNN’s medical reporting was direct on this: Biden’s case shows the cost of stopping health monitoring past a certain age simply because official guidelines suggest it.
The U.S. Preventive Services Task Force recommends against routine PSA screening for men 70 and older, arguing that competing causes of death at that age often outweigh the benefits of detection.
Biden’s outcome challenges that logic, at least for men who are otherwise healthy and active past 70.
Here is what his specific case tells older American men:
- Stopping screening early has real costs: Biden went over a decade without a prostate cancer screen. By the time urinary symptoms led to a physical exam, the cancer had already spread to the bone. The American Cancer Society told NPR that prostate cancer is highly survivable when caught early, and remains the second leading cause of cancer death in men when it is not.
- Physical activity continues to matter after diagnosis: Denis at BU’s Shipley Center points to research linking vigorous exercise to reduced risk of disease progression and mortality. Biden’s active schedule up to his diagnosis is a documented positive factor in his case.
- Health status matters more than birth year: Drs. Cookson and Stratton, writing in Urology Times, argue that screening and treatment decisions must be based on individual health profiles and functional status, not on calendar age. An 82-year-old with no major organ failure is a different clinical case than one with multiple serious conditions.
- Hormone-sensitive cancer in older men responds to treatment: Biden’s diagnosis came with one medically specific piece of good news: the cancer still responds to hormone-based therapy. That window exists now. Using it aggressively is what gives older patients the best shot at extended survival and maintained function.
Urology Times noted that Biden’s public disclosure added a real voice to the conversation on men’s health. Awareness tied to headlines fades fast. The practical takeaway does not: get screened, stay active, treat early.
Conclusion
Joe Biden’s life expectancy cannot be reduced to a single number. His metastatic prostate cancer, confirmed at a Gleason score of 9 with bone involvement, statistically places his five-year survival probability at around 37%, per NCI data cited by AJMC. Statistics, though, describe populations. Biden is one person.
He has already outlived the average American male, per CDC NCHS data. His hormone-sensitive diagnosis keeps treatment options available.
Physicians at Michigan Medicine and researchers at Boston University’s Shipley Center agree on one point: individual outcomes depend on treatment response, physical condition, and overall health. Not age alone.
His Biden prostate cancer prognosis is serious. The evidence, though, gives real reason to think he has years ahead, not months.
Frequently Asked Questions
What are Biden’s Chances of Surviving Prostate Cancer?
Based on NCI data cited by the American Cancer Society, the five-year survival rate for metastatic prostate cancer is 37%. Biden’s hormone-sensitive diagnosis improves those odds by keeping treatment options available.
Is Biden’s Prostate Cancer Curable?
No. Once prostate cancer spreads to the bone, it is not curable. However, as Northwestern University oncologist Maha Hussain told Science News, it is “very much treatable,” with the clinical goal being long-term disease management.
How Long can Someone Live with a Gleason Score of 9 and Bone Metastasis?
Survival ranges from four to ten years depending on treatment response, per oncologists cited by the Associated Press via PBS NewsHour. Men whose cancer stays hormone-sensitive consistently show longer survival times.
